en
Studia Iuridica

ADMISSIBILITY OF HEMP CROP OTHER THAN FIBROUS IN POLAND

2022, 95, No. 1

Paweł Gała

0000-0002-5446-3436

University of Silesia in Katowice

DOI

10.31338/2544-3135.si.2022-95.8

Publication date

14.06.2023

Publishing model

open access

License type

CC BY 4.0 Int.

Field

Law

Discipline

law

Language of publication

English

Downloads

PDF 311 KB

Article

Number of views:92

Number of downloads:49

Crossref citations:0

Altmetric score:0

Abstract

Implementation in the Polish legal system of the amendment of the Act on Counteracting Drug Addiction on 7 May 2022 allowed for a possibility of cultivating in Poland hemp other than fibrous for the needs of the pharmaceutical industry. The paper discusses the path that has led from the legalization of cannabis and its products to a gradual change of attitude both in international and national legislation. The aim of the study is also to familiarize the reader with the requirements the Polish legislator has placed on entities that intend to grow hemp other than fibrous for the production of pharmaceutical raw material.

Keywords:

cannabis,Indian hemp,cannabis cultivation,medical marijuana,medical cannabis use

Bibliography

Andre C.M., Hausman J.F., Guerriero G., Cannabis sativa: The plant of the thousand and one molecules, "Frontiers in Plant Science" 2016

https://doi.org/10.3389/fpls.2016.00019

Ashton C.H., Pharmacology and effects of cannabis: A brief review, "The British Journal of Psychiatry" 2001, Vol. 178, issue 2

https://doi.org/10.1192/bjp.178.2.101

Bołtryk P., Kryminologiczne i prawne aspekty posiadania narkotyków w Polsce (na przykładzie pochodnych konopi innych niż włókniste), Białystok 2014

Burnstein S., Cannabidiol (CBD) and its analogs: A review of their effects on inflammation, "Bioorganic & Medicinal Chemistry" 2015, No. 5

https://doi.org/10.1016/j.bmc.2015.01.059

Dzierżanowski T., Kanabinoidy - możliwości zastosowania w medycynie paliatywnej, "Medycyna Paliatywna" 2018, No. 10

https://doi.org/10.5114/pm.2018.77198

Englund A., Stone J.M., Morrison P.D., Cannabis in the arm: What can we learn from intravenous cannabinoid studies?, "Current Pharmaceutical Design" 2012, Vol. 18, issue 32

https://doi.org/10.2174/138161212802884618

Gała P., Bariery prawne twórczej hodowli nowych odmian konopi włóknistych w Polsce, (in:) E. Całka, A. Jakubecki, M. Nazar, A. Niewęgłowski, R. Poździk (red.), In varietate concordia. Księga jubileuszowa Profesora Ryszarda Skubisza, Warszawa 2022

Hill A.J., Williams C.M., Whalley B.J., Stephens G.J., Phytocannabinoids as novel therapeutic agents in CNS disorders, "Pharmacology & Therapeutic" 2012, Vol. 133, issue 1

https://doi.org/10.1016/j.pharmthera.2011.09.002

Iseger T., Bossong M., A systematic review of the antipsychotic properties of cannabidiol in humans, "Schizophrenia Research" 2015, No. 162

https://doi.org/10.1016/j.schres.2015.01.033

Kuna M., Warunki medycznego zastosowania marihuany w Polsce - aspekty prawa administracyjnego, "Przegląd Prawa Administracyjnego" 2019, No. 2

https://doi.org/10.17951/ppa.2019.2.81-93

Pacher P., Batkai S., Kunos G., The endocannabinoid system as an emerging target of pharmacotherapy, "Pharmacological Reviews" 2006, No. 58

https://doi.org/10.1124/pr.58.3.2

Rathi V. et al., Legality of worldwide cannabis use and associated economic benefits, (in:) T. Belwal, N.C. Belwal (eds.), Revolutionizing the potential of hemp and its products in changing the global economy, Springer 2022

https://doi.org/10.1007/978-3-031-05144-9_3

Strzelczyk M., Kaniewski R., Konopie siewne Cannabis sativa L. - jeden z najstarszych gatunków roślin użytkowych, "Postępy Fitoterapii" 2021, No. 1

https://doi.org/10.25121/PF.2021.22.1.53

Wagner H., Urlich-Merzenich G., Synergy research: Approaching a new generation of phytopharmaceuticals, "Phytomedicine" 2009, Vol. 16

https://doi.org/10.1016/j.phymed.2008.12.018